Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE: racecadotril added to sildenafil in pulmonary hypertension
2012-003921-13Phase 2Completed
- Sponsor
- University College London
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) comparing Racecadotril plus sildenafil with Placebo plus sildenafil (2 arms). Primary endpoint: Maximum percentage change from baseline in plasma atrial natriuretic peptide. Started May 2013; status: completed.
02
Drugs
racecadotril
03
Conditions
pulmonary hypertension (PH)pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2012-003921-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003921-13.